Taken together, the SCAT7/hnRNPK/YBX1 RNP complex plays a crucial role in carcinogenesis, and SCAT7 may be used as a prognostic marker in risk assessments as well as potential therapeutic regimens in the treatment of cancer. This evidence concerns the gene ELF3-AS1 and cancer.